Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ryosuke Hirohata"'
Autor:
Manato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundNivolumab is approved in Japan as a second-line treatment for patients with advanced esophageal squamous cell carcinoma (ESCC) resistant to fluoropyrimidine and platinum-based drugs. It is also used in adjuvant and primary postoperative the
Externí odkaz:
https://doaj.org/article/166fbe0c6f0b465aa8f698d42453af1e
Autor:
Nao Kitasaki, Yoichi Hamai, Toru Yoshikawa, Manabu Emi, Tomoaki Kurokawa, Ryosuke Hirohata, Manato Ohsawa, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 13, Iss 6, Pp 876-879 (2022)
Abstract Most primary esophageal adenocarcinomas arise from the Barrett epithelium of the distal esophagus. Thus, cancer developing from the ectopic gastric mucosa (EGM) of the proximal esophagus is extremely rare. Furthermore, recurrent adenocarcino
Externí odkaz:
https://doaj.org/article/20db5690eabe4bccbdcadef641b09fb2
Autor:
Jiayan Han, Soichiro Hayashi, Ryou-u Takahashi, Ryosuke Hirohata, Tomoaki Kurokawa, Mizuki Tashiro, Yuki Yamamoto, Morihito Okada, Hidetoshi Tahara
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 24, p 7385 (2022)
Despite significant advances in therapeutics for esophageal cancer (ESC) in the past decade, it remains the sixth most fatal malignancy, with a poor 5-year survival rate (approximately 10%). There is an urgent need to improve the timely diagnosis to
Externí odkaz:
https://doaj.org/article/54d1941cb0724136b77fdcc977d76ab7
Autor:
Ryosuke Hirohata, Tomoyuki Abe, Hironobu Amano, Tsuyoshi Kobayashi, Masahiro Nakahara, Hideki Ohdan, Toshio Noriyuki
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background Left-sided gallbladder is a relatively rare anatomical variation that is frequently associated with a biliary system anomaly. Here, we describe a case of left-sided gallbladder with acute cholecystitis treated by laparoscopic chol
Externí odkaz:
https://doaj.org/article/293843501c5045d189313ab735d57087
Autor:
MANABU EMI, YOICHI HAMAI, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OHSAWA, TOMOAKI KUROKAWA, YUJI MURAKAMI, IKUNO NISHIBUCHI, MORIHITO OKADA
Publikováno v:
Cancer Diagnosis & Prognosis; May/Jun2024, Vol. 4 Issue 3, p276-280, 5p
Autor:
Manato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada
Publikováno v:
Surgery Today.
Autor:
Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Manato Ohsawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada
Publikováno v:
OncoTargets and Therapy.
Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Manato Ohsawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada Department of Surgical Oncology, Hiroshima University, Hiroshima, JapanCorrespondence: Yoichi Hamai, Department of S
Autor:
Ryosuke, Hirohata, Yoichi, Hamai, Jun, Hihara, Manabu, Emi, Tomoaki, Kurokawa, Toru, Yoshikawa, Manato, Ohsawa, Nao, Kitasaki, Morihito, Okada
Publikováno v:
World Journal of Surgery. 46:1934-1943
It is occasionally difficult to diagnose cT3 or cT4b using imaging examinations for esophageal cancer. The optimal treatment strategy for borderline resectable esophageal squamous cell carcinoma (BR-ESCC) is unclear.We included 131 patients with cT3
Autor:
Manabu, Emi, Yoichi, Hmai, Toru, Yoshikawa, Ryosuke, Hirohata, Manato, Osawa, Morihito, Okada, Yuji, Murakami, Ikuno, Nishibuchi
Publikováno v:
Anticancer Research. 42:2791-2795
Surgical resection and chemoradiotherapy (CRT) can be performed as additional treatments for superficial esophageal cancer after endoscopic resection, but the selection criteria vary depending on the institution. We retrospectively evaluated the outc
Autor:
Manato, Ohsawa, Yoichi, Hamai, Manabu, Emi, Yuta, Ibuki, Tomoaki, Kurokawa, Toru, Yoshikawa, Ryosuke, Hirohata, Nao, Kitasaki, Morihito, Okada
Publikováno v:
Anticancer Research. 42:1499-1507
Trimodal therapy is frequently used for patients with locally advanced, resectable oesophageal cancer. However, it does not provide a satisfactory prognosis. The neutrophil-to-lymphocyte ratio (NLR) is an important indicator of patients' inflammatory